NCT00575523View on ClinicalTrials.gov

Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

January 31, 2008

Conditions
ArrhythmiaRespiratory Arrest
Interventions
DRUG

Atropine

Atropine 0,5mg is administered once intravenously immediately before starting percutaneous ethanol instillation.

DRUG

Placebo

1ml 0,9% Saline solution is administered intravenously immediately before starting percutaneous ethanol instillation.

Trial Locations (1)

1090

Div. of Gastroenterology and Hepatology, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00575523 - Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy | Biotech Hunter | Biotech Hunter